Covered and growing — but thin income. A 0.85% yield on an 8.4% trailing payout is trivially covered: $0.33 a quarter, raised in February 2026 from $0.27, with most earnings going to buybacks instead of the dividend. The dividend grows fast in percentage terms, but from a small base — this is a growth story that happens to pay, not an income holding.
Key risk: Middle-income life and supplemental health concentration — sales run through direct-to-consumer and agency channels that depend on recruiting and persistency; a lapse or sales slump hits the growth leg this card leans on.
Changes if: The quarterly raise pattern breaks, or the payout climbs past 25% while the yield stays under 1%. Either would remove the reason to hold it for income at all.
- ✓Payout-coverage check: 8.4% of trailing earnings — $1.32 a year against earnings that cover it more than ten times over. One of the widest cushions on the site.
- !Yield check: 0.85% indicated — $0.33/qtr × 4 at the $154.79 close on Oct. 23, 2026. Real and earned, but thin: a holder gets under $1 of annual income per $100 invested.
- ✓Dividend growth check: Raised in February 2026 from $0.27 to $0.33, a 22% increase, continuing a run of annual raises.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.